Results for:(124 found)
Jan 24, 2012 11:33AM on Top StocksBy MSN Money Partner

Zynga is initiated with 'outperform,' and Deutsche Banks is downgraded to 'neutral.'

Jan 9, 2012 5:05PM on Top StocksBy MSN Money Partner

Bristol joins Gilead, Merck, Vertex, Roche and others in a race to treat hepatitis c.

Tags: BMYMRK
Jan 9, 2012 11:30AM on Top StocksBy MSN Money Partner

Travelers is upgraded to 'conviction buy' at Goldman, while Akamai is downgraded to 'sell' at Citigroup.

Jan 5, 2012 11:52AM on Top StocksBy The Fiscal Times

When it comes to buying the index's highest-yielding dividend stocks, the real question may well be 'Why not?'

Jan 3, 2012 1:38PM on Top StocksBy MoneyShow.com

Surprising 2011 outperformance has left many big Dow stocks close to overbought, but several strong performers still have upside potential.

Dec 29, 2011 4:01PM on Top StocksBy Motley Fool Pick of the Day

The new slate of picks is almost ready, but what does it mean for the coming year?

Dec 23, 2011 1:21PM on Top StocksBy Trefis

Branded drugs are set to lose over $100 billion in revenue in the next few years, and Merck, like other large pharma companies, will need to develop new drugs to offset these losses.

Tags: JNJMRKPFE
Dec 20, 2011 3:13PM on Top StocksBy Kim Peterson

Major drugmakers are jumping into the potentially lucrative business of treating canine influenza.

Tags: MRKPFE

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More